The size of the endoscopy devices industry was estimated to have reached nearly $55 billion in 2023. Some of the growth drivers for endoscopic medical devices include the less invasive facets of the devices reducing recovery times, the aging population requiring more endoscopic intervention, and the trend of seeking to detect cancer at earlier stages. The following are among the issues discussed during this fascinating podcast:
- How do the economics of endoscopic devices disposability compare to the economics of sterilization?
- What are the benefits of using minimally invasive endoscopic devices in terms of the administration of anesthesia and recovery times?
- To what extent can endoscopy devices self-steer? Operate within the confines of blood vessels?
- Where do supply chain vulnerabilities lie in the manufacturing of endoscopy medical devices?
- What kinds of fast-track programs does the FDA have for endoscopic medical devices?
- Where do the intersections of endoscopic medical devices and pharmaceutical delivery lie?
- To what extent may accounting practices disfavor the procurement of disposable endoscopic medical devices?
- How are minimally invasive devices received by medical insurers?
- What could be the impact of quantum computing on endoscopic medical devices?
- Which medical procedures are not well-positioned for endoscopic intervention?
Guest Speaker: John Krall has served as a senior medical device executive at OwensCorning, Baxter, Medtronic, Zimmer Biomet, Small Bone Innovations, and Luminus.
John Krall